Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial to Evaluate the Efficacy of Digital Breast Tomosynthesis in Reggio Emilia Breast Cancer Screening Program in the 45-74 Age Group

NCT02698202 is registered in ClinicalTrials.gov with Azienda USL Reggio Emilia - IRCCS as lead sponsor.

NCT NCT02698202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02698202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial to Evaluate the Efficacy of Digital Breast Tomosynthesis in Reggio Emilia Breast Cancer Screening Program in the 45-74 Age Group
Lead sponsor
Azienda USL Reggio Emilia - IRCCS
Phase
Not applicable
Overall status
Completed
Start date
March 10, 2014
Completion date
December 31, 2019
Enrollment
26,877 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer